Optiflow™ Junior in Practice

Discover how clinicians around the world are using Optiflow™ Junior to improve patient care and outcomes.

Evidence of the Momentum

The use of Nasal High Flow therapy is increasing across the globe. Three surveys of practice found that approximately 70% of respondents across the United Kingdom, United States of America, Australia and New Zealand reported using Nasal High Flow1,2,3.

With growing clinical evidence supporting the therapy, it is helping more premature babies and infants every day.

Optiflow Junior is now available in over 90 countries worldwide.

Optiflow Junior helps neonates, infants and children

Explore how Optiflow Junior has contributed in a shift in clinical practice for both neonates and pediatrics.

Optiflow Junior wins Best Design Awards

Explore how Optiflow Junior has been winning internationally recognized design awards.

Optiflow Junior wins Best Design Awards

Optiflow Junior wins Best Design Awards